IBM to sell Watson Health assets

IBM (NYSE: IBM) announced today that it will sell healthcare data and analytics assets from its Watson Health business to Francisco Partners.

Financial terms were not disclosed for the deal, expected to close in the second quarter of this year subject to customary regulatory clearances. But Bloomberg cites people familiar with the plans saying that the deal size is close to $1 billion.

“Today’s agreement with Francisco Partners is a clear next step as IBM becomes even more focused on our platform-based hybrid cloud and AI strategy,” said Tom Rosamilia, SVP of IBM Software.

“IBM remains committed to Watson, our broader AI business, and to the clients and partners we support in healthcare IT. Through this transaction, Francisco Partners acquires data and analytics assets that will benefit from the enhanced investment and expertise of a healthcare-industry-focused portfolio,” Rosamilia said in a news release.

Current management will remain in s…

Read more
  • 0

Abbott to sell its STARLIMS informatics product suite

Global investment firm Francisco Partners announced today that it has agreed to acquire Abbott’s STARLIMS informatics product suite for an undisclosed amount.

Companies in the life sciences, pharma and biotech, chemical and refining, food and beverage, manufacturing, environmental, public health and forensics sectors have used the STARLIMS suite of products for more than 35 years.

The software helps organizations to manage the collection, processing, storage, retrieval and analysis of information generated in laboratories. It’s meant to improve quality and safety throughout the entire product lifecycle, starting with R&D.

The software boasts 1,100 customers across 60 countries.

“The STARLIMS technology is a leader in data and workflow management for laboratories across the globe. With the constantly changing landscape of quality manufacturing coupled with substantial industry tailwinds, we believe the business is well positioned fo…

Read more
  • 0